Nomura Holdings Inc Iovance Biotherapeutics, Inc. Transaction History

Nomura Holdings Inc

$41.1 Billion
Q3 2024

A detailed history of Nomura Holdings Inc transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 61,689 shares of IOVA stock, worth $502,148. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,689

Previous 14,175 335.2%

Holding current value

$502,148

Previous $113,000 412.39%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.28 - $11.9 $345,901 - $565,416	47,514 Added 335.2%	61,689 $579,000
Q2 2024 Aug 14, 2024	SELL	$7.78 - $14.19 $30,653 - $55,908	-3,940 Reduced 21.75%	14,175 $113,000
Q1 2024 May 15, 2024	BUY	$7.59 - $17.47 $137,492 - $316,469	18,115 New	18,115 $268,000
Q4 2023 Feb 14, 2024	SELL	$3.3 - $8.89 $38,781 - $104,475	-11,752 Reduced 16.9%	57,807 $469,000
Q3 2023 Nov 14, 2023	SELL	$4.44 - $8.79 $828,060 - $1.64 Million	-186,500 Reduced 72.83%	69,559 $316,000
Q2 2023 Aug 14, 2023	SELL	$5.36 - $9.06 $616,400 - $1.04 Million	-115,000 Reduced 30.99%	256,059 $1.8 Million
Q1 2023 May 15, 2023	SELL	$5.53 - $8.22 $3.57 Million - $5.3 Million	-644,679 Reduced 63.47%	371,059 $2.27 Million
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $193,631 - $344,540	34,454 Added 3.51%	1,015,738 $6.48 Million
Q3 2022 Nov 15, 2022	SELL	$9.53 - $13.11 $1.6 Million - $2.2 Million	-168,117 Reduced 14.63%	981,284 $9.41 Million
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $7.33 Million - $21.1 Million	1,149,401 New	1,149,401 $13.2 Million
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $195,959 - $396,840	-12,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $344,040 - $631,080	12,000 New	12,000 $380,000
Q3 2020 Nov 12, 2020	SELL	$27.75 - $36.3 $277,500 - $363,000	-10,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $272,100 - $410,000	10,000 New	10,000 $275,000
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $893,813 - $2.24 Million	-91,392 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$8.41 - $11.26 $256,605 - $343,565	30,512 Added 50.12%	91,392 $891,000
Q4 2018 Feb 14, 2019	BUY	$7.51 - $11.93 $457,208 - $726,298	60,880 New	60,880 $538,000

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account

Nomura Holdings Inc Iovance Biotherapeutics, Inc. Transaction History